Alinity i Anti-HBc (List Number 07P84)

FDA Premarket Approval P080023 S038

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceAlinity i Anti-HBc (List Number 07P84)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantAbbott Laboratories100 Abbott Park Rd.ap5n-2, Dept. 09vbabbott Park, IL 60064 PMA NumberP080023 Supplement NumberS038 Date Received09/27/2022 Decision Date10/25/2022 Product Code LOM  Advisory Committee Microbiology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Date Received2022-09-27
Decision Date2022-10-25
PMAP080023
SupplementS038
Product CodeLOM 
Advisory CommitteeMicrobiology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination ProductNo
Applicant AddressAbbott Laboratories
100 Abbott Park Rd.
ap5n-2, Dept. 09vb
abbott Park, IL 60064 PMA NumberP080023 Supplement NumberS038 Date Received09/27/2022 Decision Date10/25/2022 Product Code LOM  Advisory Committee Microbiology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No Combination ProductNo Approval Order Statement  
addition Of A New Fill Line In Existing Manufacturing Space

Supplemental Filings

Supplement NumberDateSupplement Type
P080023Original Filing
S038 2022-09-27 30-day Notice
S037 2022-09-14 30-day Notice
S036 2021-11-18 30-day Notice
S035 2021-11-09 30-day Notice
S034 2021-02-09 Real-time Process
S033 2020-03-16 Normal 180 Day Track No User Fee
S032 2020-03-16 Normal 180 Day Track No User Fee
S031
S030 2018-10-12 30-day Notice
S029 2018-07-13 30-day Notice
S028 2017-12-21 Normal 180 Day Track
S027 2015-07-16 30-day Notice
S026 2014-11-13 30-day Notice
S025 2014-09-19 30-day Notice
S024 2013-10-30 30-day Notice
S023 2013-10-28 30-day Notice
S022 2013-09-04 30-day Notice
S021 2013-02-15 30-day Notice
S020 2013-02-11 30-day Notice
S019 2012-11-19 30-day Notice
S018 2012-11-15 30-day Notice
S017 2012-11-13 30-day Notice
S016 2012-11-01 30-day Notice
S015 2012-08-03 30-day Notice
S014 2012-03-22 30-day Notice
S013 2012-03-15 30-day Notice
S012 2011-11-23 Special (immediate Track)
S011 2011-10-28 135 Review Track For 30-day Notice
S010 2011-10-28 30-day Notice
S009 2011-05-25 30-day Notice
S008 2011-05-04 Normal 180 Day Track No User Fee
S007 2011-04-18 30-day Notice
S006 2011-02-17 Normal 180 Day Track No User Fee
S005 2010-12-28 135 Review Track For 30-day Notice
S004 2010-12-22 Special (immediate Track)
S003 2010-11-01 Normal 180 Day Track No User Fee
S002 2010-06-22 Normal 180 Day Track No User Fee
S001 2009-06-19 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
00380740011123 P080023 001
00380740011116 P080023 001
00380740011109 P080023 001
00380740136666 P080023 028
00380740136659 P080023 028
00380740136642 P080023 028
00380740136635 P080023 028

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.